Wada, Yoshimitsu
Takei, Yuji
Minezumi, Takumi
Hirashima, Hiroto
Fujiwara, Hiroyuki
Article History
Received: 27 August 2022
Accepted: 23 February 2023
First Online: 15 March 2023
Declarations
:
: Our study was approved by the ethics committee of Sano Kosei General Hospital [approval number: 202120 (Feb. 7th, 2022)]. There is no need for written consent to participate to be obtained because this study is a retrospective study. We informed patients of this study using an opt-out approach. The opt-out approach was approved by the ethics committee of Sano Kosei General Hospital. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: Authors YW and HH received payments for lectures at educational events from Aska pharmaceutical Co., Ltd. The funding source played no role in the design, practice, or analysis of this study. Remaining all authors don't have any Competing interests.